» Articles » PMID: 29960034

Identification of 7α,24-dihydroxy-3-oxocholest-4-en-26-oic and 7α,25-dihydroxy-3-oxocholest-4-en-26-oic Acids in Human Cerebrospinal Fluid and Plasma

Overview
Journal Biochimie
Specialty Biochemistry
Date 2018 Jul 1
PMID 29960034
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Dihydroxyoxocholestenoic acids are intermediates in bile acid biosynthesis. Here, using liquid chromatography - mass spectrometry, we confirm the identification of 7α,24-dihydroxy-3-oxocholest-4-en-26-oic and 7α,25-dihydroxy-3-oxocholest-4-en-26-oic acids in cerebrospinal fluid (CSF) based on comparisons to authentic standards and of 7α,12α-dihydroxy-3-oxocholest-4-en-26-oic and 7α,x-dihydroxy-3-oxocholest-4-en-26-oic (where hydroxylation is likely on C-22 or C-23) based on exact mass measurement and multistage fragmentation. Surprisingly, patients suffering from the inborn error of metabolism cerebrotendinous xanthomatosis, where the enzyme CYP27A1, which normally introduces the (25 R)26-carboxylic acid group to the sterol side-chain, is defective still synthesise 7α,24-dihydroxy-3-oxocholest-4-en-26-oic acid and also both 25 R- and 25 S-epimers of 7α,12α-dihydroxy-3-oxocholest-4-en-26-oic acid. We speculate that the enzymes CYP46A1 and CYP3A4 may have C-26 carboxylase activity to generate these acids. In patients suffering from hereditary spastic paraplegia type 5 the CSF concentrations of the 7α,24- and 7α,25-dihydroxy acids are reduced, suggesting an involvement of CYP7B1 in their biosynthesis in brain.

Citing Articles

Bile acid receptors and signaling crosstalk in the liver, gut and brain.

Ferrell J, Chiang J Liver Res. 2025; 5(3):105-118.

PMID: 39957847 PMC: 11791822. DOI: 10.1016/j.livres.2021.07.002.


Cholesterol metabolism: from lipidomics to immunology.

Griffiths W, Wang Y J Lipid Res. 2021; 63(2):100165.

PMID: 34953867 PMC: 8953665. DOI: 10.1016/j.jlr.2021.100165.


The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson's Disease and Their Association With Disease State and Clinical Features.

Griffiths W, Abdel-Khalik J, Moore S, Wijeyekoon R, Crick P, Yutuc E Front Aging Neurosci. 2021; 13:685594.

PMID: 34526889 PMC: 8435905. DOI: 10.3389/fnagi.2021.685594.


Cholesterol metabolism pathways - are the intermediates more important than the products?.

Wang Y, Yutuc E, Griffiths W FEBS J. 2021; 288(12):3727-3745.

PMID: 33506652 PMC: 8653896. DOI: 10.1111/febs.15727.


The Biosynthesis of Enzymatically Oxidized Lipids.

Hajeyah A, Griffiths W, Wang Y, Finch A, ODonnell V Front Endocrinol (Lausanne). 2020; 11:591819.

PMID: 33329396 PMC: 7711093. DOI: 10.3389/fendo.2020.591819.


References
1.
Schols L, Rattay T, Martus P, Meisner C, Baets J, Fischer I . Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial. Brain. 2017; 140(12):3112-3127. PMC: 5841036. DOI: 10.1093/brain/awx273. View

2.
Karu K, Hornshaw M, Woffendin G, Bodin K, Hamberg M, Alvelius G . Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. J Lipid Res. 2007; 48(4):976-87. PMC: 2315781. DOI: 10.1194/jlr.M600497-JLR200. View

3.
Norlin M, von Bahr S, Bjorkhem I, Wikvall K . On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation. J Lipid Res. 2003; 44(8):1515-22. DOI: 10.1194/jlr.M300047-JLR200. View

4.
Saeed A, Floris F, Andersson U, Pikuleva I, Lovgren-Sandblom A, Bjerke M . 7α-hydroxy-3-oxo-4-cholestenoic acid in cerebrospinal fluid reflects the integrity of the blood-brain barrier. J Lipid Res. 2013; 55(2):313-8. PMC: 3886670. DOI: 10.1194/jlr.P044982. View

5.
Ogundare M, Theofilopoulos S, Lockhart A, Hall L, Arenas E, Sjovall J . Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain?. J Biol Chem. 2009; 285(7):4666-79. PMC: 2836072. DOI: 10.1074/jbc.M109.086678. View